RT @FredLAFernandes: Separei alguns links para entender melhor as diversas fecetas da COVID 19. Textos técnicos: ARDS atípica https://t.co/…
Separei alguns links para entender melhor as diversas fecetas da COVID 19. Textos técnicos: ARDS atípica https://t.co/QpCmQG7Lc5 Caracteristicas em NYC https://t.co/DB6PfZOvR6 Heparina em COVID19 https://t.co/u7ugJReQ59 COVID leve a moderado https://t.co/
What are the signs symptoms and clinical course of Mild or Moderate #Covid19? @NEJM https://t.co/i8qhcTtmuO
RT @jacquelinetchu: I feel exceedingly lucky to have been precepted and trained through ID and HIV fellowship by this giant, @RMKGandhi. W…
There is mention of the use of chloroquine in this video. Yet articles like this say there is no clinical evidence of effectiveness of chloroquine or plaquenil for COVID19 while toxicity from side effects of medications is a major concern https://t.co/tGgz
https://t.co/uw5lWlESFu CLINICAL PRACTICE Mild or Moderate Covid-19
RT @PalmBeachCMA: Mild or Moderate #Covid19 @NEJM https://t.co/LZVcSFv4TV
RT @jacquelinetchu: I feel exceedingly lucky to have been precepted and trained through ID and HIV fellowship by this giant, @RMKGandhi. W…
Il faudra donc faire autant attention, sinon plus, car il y aura plus de monde partout, après la fin du confinement que pendant. Et ne tester que les symptomatiques est insuffisant.
Un Clinical Practice de NEJM que parece un diario de nuestros últimos 2 meses... Mild or Moderate Covid-19 | NEJM https://t.co/uaIeX6Tvzj
Mild or Moderate #Covid19 @NEJM https://t.co/LZVcSFv4TV
RT @tango_ballet: 最新のNEJM Clinical practiceは「軽症-中等症のCOVID-19」 現存するエビデンスを確認できる素晴らしい内容でした. Table 2の最下段にある「症状消失後のPCR陽性例で, まだ生きたウィルスは残存しているの…
An important review.... Mild or Moderate Covid-19 | NEJM https://t.co/4QJJ6jmd4I
RT @MAecocardio: Como debemos valorar Covi en fase inicial - no se puede decir mas realmente sintético(por eso es el NEJM) 🟡Rx torax es usu…
#medtwitter Mild or Moderate Covid-19 | NEJM https://t.co/TrOyp9J8h3
RT @jacquelinetchu: I feel exceedingly lucky to have been precepted and trained through ID and HIV fellowship by this giant, @RMKGandhi. W…
Covid-19 leve o moderado https://t.co/NlLLaeyDGC
RT @jacquelinetchu: I feel exceedingly lucky to have been precepted and trained through ID and HIV fellowship by this giant, @RMKGandhi. W…
I feel exceedingly lucky to have been precepted and trained through ID and HIV fellowship by this giant, @RMKGandhi. Whenever I have ID questions, I first ask myself what Raj would do. Read this and learn about #COVID19. It's good. https://t.co/j1fyihr3r
Clinical management of mild/moderate #Covid_19 https://t.co/rA82j1rig4
Unknowns: The contribution of transmission from asymptomatic and presymptomatic people to the community and nosocomial spread of SARS-CoV-2, and the extent to which fomites and aerosols (those not generated by medical procedures) contribute to transmission
Health care workers must be protected from acquiring SARS-CoV-2 when they are providing clinical care. Using telehealth when possible, reducing the number of health care workers who interact with infected patients, and performing health care environmental
MANAGEMENT OF MILD OR MODERATE COVID-19 Patients with mild illness usually recover at home, with supportive care & isolation in accordance with guidelines. Those at high risk for complications should have a pulse oximeter to self-monitor the oxygen sat
Additional tests sometimes performed: coagulation studies (e.g., d-dimer measurement) and inflammatory markers (e.g., C-reactive protein & ferritin), lactate dehydrogenase, creatine kinase, & procalcitonin. The prognostic value and clinical utility
Moderate or severe illness, hospitalization is generally warranted. May have dyspnea, O2 saturation at least 94% with ambient air. Indicators of severe disease: marked tachypnea (respiratory rate, ≥30 breaths per minute), hypoxemia (oxygen saturation, ≤93%
If new or worsening symptoms (e.g., dyspnea) develop with initially mild illness, additional evaluation warranted. Assess for tachypnea, hypoxemia, & abnormal lung findings. In addition, testing for other pathogens (e.g., influenza & respiratory vi
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
Some who have mild symptoms initially will subsequently have precipitous clinical deterioration that occurs approximately 1 week after symptom onset. In patients who have risk factors for severe disease, close monitoring for clinical progression is warrant
RT @bettycjung: Evaluation & management of Covid-19 is guided by severity of illness. Initial China data: 81% of people with Covid-19 had…
Evaluation & management of Covid-19 is guided by severity of illness. Initial China data: 81% of people with Covid-19 had mild or moderate disease (including people without pneumonia and people with mild pneumonia), 14% had severe disease, and 5% had
If a nasopharyngeal swab cannot be obtained (e.g., because of supply shortages), the @CDC recommends the use of an oropharyngeal swab. FDA recently recognized on-site self-collection of an anterior nares specimen as an acceptable method of collection.
Sputum samples (or endotracheal aspirates from intubated patients) may be easier to obtain in some settings, and testing of sputum may be more sensitive than testing of a nasopharyngeal swab. Sputum induction is contraindicated because of concerns about ae
When abnormalities are present on imaging, the typical findings are ground-glass opacifications or consolidation. DIAGNOSIS The diagnosis of Covid-19 is usually based on the detection of SARS-CoV-2 by means of polymerase-chain-reaction (PCR) assay.
Laboratory findings: lymphopenia, elevated levels of d-dimer, lactate dehydrogenase, C-reactive protein, & ferritin. At presentation, the procalcitonin level is typically normal.
Certain conditions (kidney disease, immunosuppression, cancer, & uncontrolled human immunodeficiency virus [HIV] infection) may confer an increased risk of complications, associated with worse outcomes after infection with other respiratory pathogens,
Risk factors for complications of Covid-19 include older age (e.g., >65 years), cardiovascular disease, chronic lung disease, hypertension, diabetes, and obesity.
RT @RickKellerMD: Thus far, one of the best objective and concise clinical practice summaries to date–based on available evidence–on #coron…
The median incubation period, from exposure to symptom onset, is approximately 4 to 5 days, and 97.5% of patients who are symptomatic will have symptoms within 11.5 days after infection. Symptoms may include fever, cough, sore throat, malaise, and myalgias
Just before or soon after symptom onset, patients have high nasopharyngeal viral levels, which then fall over the course of approximately 1 week.10 Patients with severe disease may shed the virus for longer periods, although the duration of infectious vira
A major challenge to containing spread of SARS-CoV-2 is presymptomatic people are infectious. Recent reports suggest patients may be infectious 1 to 3 days before symptom onset & up to 40-50% of cases may be attributable to transmission from asymptomat
RT @tango_ballet: 最新のNEJM Clinical practiceは「軽症-中等症のCOVID-19」 現存するエビデンスを確認できる素晴らしい内容でした. Table 2の最下段にある「症状消失後のPCR陽性例で, まだ生きたウィルスは残存しているの…
Transmission is thought not to normally occur through the inhalation of aerosols (virions suspended in air), but there are concerns that the virus may be aerosolized during certain activities (e.g., singing) or procedures (e.g., intubation or use of nebuli
SARS-CoV-2 is spread from person to person through respiratory droplets, which are typically released when an infected person coughs or sneezes. Because droplets usually fall within a few meters, the likelihood of transmission is decreased if people remain
KEY CLINICAL POINTS: Mild or Moderate Covid-19 https://t.co/zax7OedCsw #COVID19 https://t.co/2ZiTrf6XtS
Mild or Moderate #Covid19 https://t.co/gHxHT31eVh @NEJM
RT @RickKellerMD: Thus far, one of the best objective and concise clinical practice summaries to date–based on available evidence–on #coron…
RT @tango_ballet: 最新のNEJM Clinical practiceは「軽症-中等症のCOVID-19」 現存するエビデンスを確認できる素晴らしい内容でした. Table 2の最下段にある「症状消失後のPCR陽性例で, まだ生きたウィルスは残存しているの…
Thus far, one of the best objective and concise clinical practice summaries to date–based on available evidence–on #coronavirus #SARSCoV2 #COVID19. @RMKGandhi @johnLynchID @CarlosdelRio7 https://t.co/h3DT0M4AFF
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @mayogastro: Excelente artículo para aprender de la enfermedad que causa la actual pandemia. Vale la pena leerlo. Mild or Moderate Covid…
Artigo publicado no @NEJM : Covid-19 Leve ou Moderada. Link: (+) https://t.co/l7CsDXcNnX
#SARSCoV2 transmission according to stage of infection @CarlosdelRio7 @EmoryUniversity @NEJM https://t.co/HSqvhSGQfF https://t.co/lXhCePt6HD
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @JenniferSpicer4: Check out this article from @carlosdelrio7 on Mild or Moderate Covid-19 published in @NEJM https://t.co/AHEZ8Ohn80
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @mayogastro: Excelente artículo para aprender de la enfermedad que causa la actual pandemia. Vale la pena leerlo. Mild or Moderate Covid…
RT @TxID_Edu: Mild or Moderate #COVID19 Very nice review of management by @RMKGandhi @JohnLynchID @CarlosdelRio7 https://t.co/f8NV33CRJh…
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
RT @tango_ballet: 最新のNEJM Clinical practiceは「軽症-中等症のCOVID-19」 現存するエビデンスを確認できる素晴らしい内容でした. Table 2の最下段にある「症状消失後のPCR陽性例で, まだ生きたウィルスは残存しているの…
RT @tango_ballet: 最新のNEJM Clinical practiceは「軽症-中等症のCOVID-19」 現存するエビデンスを確認できる素晴らしい内容でした. Table 2の最下段にある「症状消失後のPCR陽性例で, まだ生きたウィルスは残存しているの…
最新のNEJM Clinical practiceは「軽症-中等症のCOVID-19」 現存するエビデンスを確認できる素晴らしい内容でした. Table 2の最下段にある「症状消失後のPCR陽性例で, まだ生きたウィルスは残存しているのか?感染性はあるのか?」あたりの疑問の答えが知りたい. https://t.co/EqBHokNa4i
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @MAecocardio: Como debemos valorar Covi en fase inicial - no se puede decir mas realmente sintético(por eso es el NEJM) 🟡Rx torax es usu…
Mild or Moderate Covid-19 https://t.co/hVJ86dBO3Y
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @TxID_Edu: Mild or Moderate #COVID19 Very nice review of management by @RMKGandhi @JohnLynchID @CarlosdelRio7 https://t.co/f8NV33CRJh…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…
Mild or Moderate Covid-19, from the NEJM https://t.co/Jg1WAh0wsI
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
RT @GilbertDeray: Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de trans…
Les Covid+ sont contagieux 1 à 3 jours avant le début des signes cliniques et ils représentent 40-50% des risque de transmissions du virus. Leur dépistage systémique, en testant au moins les « contacts » puis leur isolement est capital. https://t.co/zPtmaH
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
RT @hichachu: https://t.co/hyJRhSCWPf enrollment in a randomized clinical trial, if possible. When the patient’s condition improves suffici…
RT @MAecocardio: Como debemos valorar Covi en fase inicial - no se puede decir mas realmente sintético(por eso es el NEJM) 🟡Rx torax es usu…
https://t.co/hyJRhSCWPf enrollment in a randomized clinical trial, if possible. When the patient’s condition improves sufficiently for discharge, he should be advised to remain isolated for a minimum of 7 days after symptom onset and for at least 3 days af
RT @MAecocardio: Como debemos valorar Covi en fase inicial - no se puede decir mas realmente sintético(por eso es el NEJM) 🟡Rx torax es usu…
RT @MAecocardio: Como debemos valorar Covi en fase inicial - no se puede decir mas realmente sintético(por eso es el NEJM) 🟡Rx torax es usu…
アメリカの軽症者中等症診療ガイドライン 最も新しい 医療者でなくてもオススメします。、フリーで読めます。https://t.co/1vnA5HtYnf
Mild or Moderate Covid-19 | NEJM https://t.co/GtFLxJyZaK
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
RT @MAecocardio: Como debemos valorar Covi en fase inicial - no se puede decir mas realmente sintético(por eso es el NEJM) 🟡Rx torax es usu…
Mild or Moderate Covid-19 | NEJM https://t.co/Dc2QBlylkU
RT @MAecocardio: Como debemos valorar Covi en fase inicial - no se puede decir mas realmente sintético(por eso es el NEJM) 🟡Rx torax es usu…
RT @paomorejon: 📌#COVIDー19: Leve o moderado •40-50% de los casos puede ser contagio de asintomáticos •Incubación: 4-5 dís 🤧🤒 después de la…
RT @CarlosdelRio7: Excited to co-author with @RMKGandhi and @johnLynchID a Clinical Practice article published today in @NEJM entitled…